Give your trial the best chance of success.

See how IQVIA can help reduce non-enrolling sites and increase enrollment speeds up to 30%. Our insight-driven approach to site identification integrates real world data, machine learning, and predictive modeling to prioritize the best performing sites and help you reach milestones faster.

Contact us

Predict top-tier investigators for higher enrollment rates

Through the power of the IQVIA CORE, our clinical trial experts can bypass the low performers and instead prioritize the top potential recruiters -- speeding enrollment and your study completion. To validate this approach, we put it to the test against the universe of our >500 ongoing clinical studies. See the impact based on actual enrollment rates below.

IQVIA™ CORE
IQVIA™ CORE

Site identification powered by analytics, not opinions

In traditional clinical trials, sites are selected based on experience and relationships – with less than stellar results. IQVIA has developed a more precise way to predict the best-performing sites and investigators. This approach integrates

  • Unmatched data, including observed quality and risk factors, patient access, site location and previous experience
  • Advanced analytics to predict site performance using models to identify the most appropriate investigators based on the indication and the sites most likely to achieve highest enrollment
  • Transformative technology to integrate data and provide insights to identify best-performing sites
  • Extensive trial expertise to assess quality of sites based on key risk indicators and to guide and interpret the process
doctor reviewing information on clipboard with patient
doctor reviewing information on clipboard with patient

A network of high-performing sites

IQVIA has alliances with investigators in clinics and hospitals of every size, linked to prime and partner sites worldwide. This global reach lets us identify the right patients - and engage the right sites - to go from insight to action. 

RELATED SOLUTIONS
Protocol Design

Assess your protocol against real world evidence using advanced analytics, and reduce the risk of costly amendments.

Phase I Trials

Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.

Phase IIb/III Trials

Improve the performance of your clinical trials with the power of the IQVIA CORE.

Patient Recruitment

Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.

Global Laboratories

Access central labs around the globe through Q2 Solutions, a joint venture between IQVIA and Quest Diagnostics.

Clinical Acceleration

Avoid the cost of failed sites and shorten trial timelines with evidence-based site activation and engagement technologies.

Contact Us
Contact Us

Email Us

Interested in learning more about how IQVIA can create solutions to help you drive healthcare forward?

Call Us

We're available during standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.